KRAS and colorectal carcinoma: In particular, CRC NRAS mutations seem to be a different molecular subset, enriched in left-sided primary tumors and among African Americans, associated with a poorer prognosis and worse outcomes than either KRAS-mutant or wild-type CRC [50].